Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Pediatric multiple sclerosis.

Mowry EM, Waubant E.

Continuum (Minneap Minn). 2010 Oct;16(5 Multiple Sclerosis):181-92. doi: 10.1212/01.CON.0000389941.99907.c8.

PMID:
22810605
2.

Emerging concepts in pediatric-onset multiple sclerosis and related disorders.

Tenembaum SN.

Curr Opin Pediatr. 2010 Dec;22(6):726-30. doi: 10.1097/MOP.0b013e3283402b8a. Review.

PMID:
20885330
3.

Pediatric multiple sclerosis.

Chabas D, Strober J, Waubant E.

Curr Neurol Neurosci Rep. 2008 Sep;8(5):434-41. Review.

PMID:
18713581
4.

Clinical features of children and adolescents with multiple sclerosis.

Ness JM, Chabas D, Sadovnick AD, Pohl D, Banwell B, Weinstock-Guttman B; International Pediatric MS Study Group..

Neurology. 2007 Apr 17;68(16 Suppl 2):S37-45. Review.

PMID:
17438237
5.

Treatment of pediatric multiple sclerosis and variants.

Pohl D, Waubant E, Banwell B, Chabas D, Chitnis T, Weinstock-Guttman B, Tenembaum S; International Pediatric MS Study Group..

Neurology. 2007 Apr 17;68(16 Suppl 2):S54-65. Review.

PMID:
17438239
6.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
7.

Pediatric and adolescent multiple sclerosis.

Sluder JA, Newhouse P, Fain D.

Adolesc Med. 2002 Oct;13(3):461-85. Review.

PMID:
12270795
8.

Epidemiology of Hodgkin's disease.

Grufferman S, Delzell E.

Epidemiol Rev. 1984;6:76-106. Review.

PMID:
6092122
9.

Epstein-barr virus infection and multiple sclerosis: a review.

Ascherio A, Munger KL.

J Neuroimmune Pharmacol. 2010 Sep;5(3):271-7. doi: 10.1007/s11481-010-9201-3. Review.

PMID:
20369303
10.

Emerging disease modifying therapies for multiple sclerosis.

Waubant E.

Expert Opin Emerg Drugs. 2003 May;8(1):145-61. Review.

PMID:
14610918
11.

[Multiple sclerosis and Epstein-Barr virus : new developments and perspectives].

Ruprecht K.

Nervenarzt. 2008 Apr;79(4):399-407. Review. German.

PMID:
17713752
12.

What is new in the treatment of multiple sclerosis?

Weinstock-Guttman B, Jacobs LD.

Drugs. 2000 Mar;59(3):401-10. Review.

PMID:
10776827
13.

Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Oreja-Guevara C, Wiendl H, Kieseier BC, Airas L; NeuroNet Study Group..

Ther Adv Neurol Disord. 2014 Mar;7(2):137-49. doi: 10.1177/1756285613501575. Review.

14.

Childhood autoimmune neurologic diseases of the central nervous system.

Jones CT.

Neurol Clin. 2003 Nov;21(4):745-64. Review.

PMID:
14743647
15.

Pediatric multiple sclerosis: analysis of clinical and epidemiological aspects according to National MS Society Consensus 2007.

Ferreira ML, Machado MI, Dantas MJ, Moreira AJ, Souza AM.

Arq Neuropsiquiatr. 2008 Sep;66(3B):665-70.

16.

Diagnosis and Management of Multiple Sclerosis in Children.

Najafi MR, Najafi MA, Nasr Z.

Iran J Child Neurol. 2016 Summer;10(3):13-23. Review.

Items per page

Supplemental Content

Support Center